国: フィリピン
言語: 英語
ソース: FDA (Food And Drug Administration)
Japanese Encephalitis Virus (Live, Attenuated)
N/A; Importer: Zuellig Pharma Corporation; Distributor: Zuellig Pharma Corporation
Japanese Encephalitis Virus (Live, Attenuated)
Formulation: After reconstitution, one dose (0.5 mL) contains 4.0-5.8 log Plaque Forming Units (PFU) live, attenuated, recombinant Japanese Encephalitis Virus.
Powder for Suspension for Injection (SC)
Packaging: Multi-dose vial (four doses). One box contains Type I glass vial with VVM (powder), 2 mL Type I glass vial (0.9% Sterile Sodium Solution as diluent), each equipped with halobutyl stopper and flip-off cap. (Box of 10's)., Packaging: Multi-dose vial (four doses). One box contains Type I glass vial with VVM (powder), 2 mL Type I glass vial (0.9% Ster
Government Pharmaceutical Organization - Merieux Biological Products Co., Ltd., Thailand
Formulation: After reconstitution, one dose (0.5 mL) contains 4.0-5.8 log Plaque Forming Units (PFU) live, attenuated, recombinant Japanese Encephalitis Virus.
2022-07-13